Histamina Hal Allergy (Histamine Dihydrochloride)

Histamina Hal Allergy is used as a standardized reagent for skin prick testing to identify IgE‑mediated allergic sensitization.

• Conduct skin prick tests for suspected food, inhalant, or drug allergies.
• Provide a positive control reaction to confirm test reliability.
• Assist in differentiating between allergic and non‑allergic rhinitis.
• Support allergists in determining the need for further immunologic evaluation.

• Histamina Hal Allergy acts as a non‑specific histamine receptor agonist. When applied to the skin, it binds to H1 receptors on vascular endothelial cells, causing vasodilation and increased vascular permeability. This leads to fluid extravasation and the formation of a wheal, while surrounding mast cell degranulation produces a flare. The resulting wheal‑and‑flare response serves as a measurable indicator of histamine reactivity during allergy skin testing.

Local and systemic reactions may occur after skin application of Histamina Hal Allergy.

Common

• Redness (erythema) at the test site.
• Swelling (wheal) up to 5 mm in diameter.
• Itching or mild pruritus around the puncture.
• Transient warmth or tingling sensation.

Serious

• Large wheal exceeding 10 mm indicating hypersensitivity.
• Severe urticaria extending beyond the test area.
• Anaphylactic symptoms such as difficulty breathing, hypotension, or widespread rash.
• Persistent edema lasting more than 30 minutes.

When using Histamina Hal Allergy, clinicians should observe several precautionary measures to ensure patient safety.

• Verify patient’s history of severe allergic reactions or anaphylaxis before testing.
• Avoid testing on broken, inflamed, or infected skin.
• Do not use in patients taking antihistamines or recent corticosteroid therapy without appropriate washout.
• Keep the test area under observation for at least 15 minutes after application.
• Have emergency equipment and epinephrine readily available.
• Document the size of the wheal and compare with control reactions.

Histamina Hal Allergy may interact with medications or conditions that alter histamine pathways or skin reactivity.

Avoid

• Concurrent use of systemic antihistamines (e.g., cetirizine, diphenhydramine) that suppress the wheal‑and‑flare response.
• Recent topical antihistamine or corticosteroid creams applied to the test site.
• Ongoing treatment with mast‑cell stabilizers (e.g., cromolyn) that may blunt the reaction.

Use with caution

• Patients on low‑dose oral corticosteroids, as the response may be reduced but not absent.
• Individuals receiving beta‑blockers, which can affect management of potential anaphylaxis.
• Elderly patients with fragile skin, where exaggerated local reactions may occur.